Present situation and new perspectives for vaccination against Neisseria meningitidis in Tuscany, Central Italy

Journal of Preventive Medicine and Hygiene

Volumn 53, Issue 2, 2012, Pages 61-67

  Bechini, A ^a   Levi, M ^a   Boccalini, S ^a   Tiscione, E ^a   Ceccherini, V ^a   Taddei, C ^a   Balocchini, E ^b   Bonanni, P ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Tuscany Regional Health Authority   (Italy)

Author keywords

Neisseria meningitidis; Prevention; Vaccination strategies

Indexed keywords

MENINGOCOCCUS VACCINE;

ADOLESCENT; ADULT; AGED; CHILD; HUMAN; INCIDENCE; ITALY; MENINGITIS; NEISSERIA MENINGITIDIS; NONHUMAN; PRESCHOOL CHILD; PROPHYLAXIS; REVIEW; SCHOOL CHILD; VACCINATION;

CHILD; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; INFANT; INFANT, NEWBORN; ITALY; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; NEISSERIA MENINGITIDIS; POPULATION SURVEILLANCE; PREVALENCE;

EID: 84864657209     PISSN: 11212233     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Wilder-Smith A. Meningococcal vaccine in travelers. Curr Opin Infect Dis. 2007;20(5):454-60. (Pubitemid 47359640)
2. CDC-ACIP. Prevention and control of meningococcal disease. MMWR 2005;54:1-21.
3. European Union Invasive Bacterial Infections Surveillance Network (EUIBIS). Invasive Neisseria meningitidis in Europe. London: Health Protection Agency 2006 [http://www.hpa-bioinformatics.org.uk/euibis/documents/2006-meningo. pdf (accessed on June 14, 2012).
4. Stroffolini T, Congiu ME, Occhionero M, et al. Meningococcal disease in Italy. J Infect. 1989;19(1):69-74. (Pubitemid 19215141)
5. Stroffolini T, Curianó CM, Congiu ME, et al. Trends in meningococcal disease in Italy 1987. Public Health. 1989;103(1):31-4. (Pubitemid 19060848)
6. Stroffolini T, Carbonari P. Meningococcal disease in Italy in 1989. Eur J Epidemiol. 1992;8(1):114-6.
7. Stroffolini T, Carbonari P. Meningococcal disease in Italy in 1990. Microbiologica. 1991;14(4):333-6.
8. Salmaso S, Mastrantonio P, Scuderi G, et al. Pattern of bacterial meningitis in Italy, 1994. Eur J Epidemiol. 1997;13(3):317-21. (Pubitemid 27306078)
9. Mastrantonio P, Stefanelli P, Fazio C, et al. Serotype distribution, antibiotic susceptibility, and genetic relatedness of Neisseria meningitidis strains recently isolated in Italy. Clin Infect Dis. 2003;36(4):422-8. (Pubitemid 36241307)
10. Girard MP, Preziosi MP, Aguado MT, et al. A review of vaccine research and development: meningococcal disease. Vaccine 2006;24:4692-700. (Pubitemid 43776790)
11. Campbell H, Borrow R, Salisbury D, et al. Meningococcal C conjugate vaccine: the experience in England and Wales. Vaccine 2009;27 Suppl 2:B20-9.
12. Trotter CL, Ramsay ME. Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines. FEMS Microbiol Rev 2007;31:101-7.11.
13. Italian Ministry of Health. National Prevention Plan 2012-2014. Available from: http://www.salute.gov.it/imgs/C-17-pubblicazioni-1721-allegato.pdf (accessed on June 14, 2012).
14. Regione Toscana. DGR n. 379 del 7/03/2005. Direttive in materia di vaccinazioni e indirizzi per la stesura del nuovo calendario regionale delle vaccinazioni. Modifiche alla delibera G.R. 24.11.2003 n. 1249. BURT n. 13 del 30.03.2005.
15. European Medicines Agency. Committee for Medicinal Products for Human Use (CHMP). Menveo: Summary of opinion (post authorisation). EMA/CHMP/187861/2012. Available from: http://www.ema.europa.eu/docs/en-GB/document-library/Summary-of- opinion/human/001095/WC500124220.pdf.
16. Geodemo. ISTAT [Italian National Institute of Statistics]. Available from: http://demo.istat.it/(last accessed 25 January 2012).
17. Istituto Superiore di Sanità[Italian National Health Institute]. Sistema Informatizzato Malattie Infettive (SIMI) [Infectious Diseases Information System]. Dati di sorveglianza sulle meningiti [Surveillance data on meningitis]. Available from: http://www.simi.iss.it/dati.htm (last accessed 29 March 2012).
18. Istituto Superiore di Sanità ICONA 2008: Indagine di Copertura vaccinale Nazionale nei bambini e negli adolescenti. Gruppo di lavoro ICONA. Rapporti ISTISAN 09/29 2009;viii [Italian].
19. Stefanelli P, Fazio C, Sofia T, et al. Serogroup C meningococci in Italy in the era of conjugate menC vaccination. BMC Infect Dis 2009;9:135.
20. EU-IBIS. European Union Invasive Bacterial Infections Surveillance Network. EU-IBIS 2006 [cited 2006 Apr 27]; Available from: URL: http://www.euibis.org.
21. Fazio C, Neri A, Starnino S, et al. Characterization of invasive serogroup Y meningococci in Italy: prevalence of ST-23 Complex/Cluster A3. New Microbiol 2008;31:467-72.
22. CDC. Travelers' Health: Yellow Book 2012 edition.
23. Lingappa JR, Al-Rabeah AM, Hajjeh R, et al. Serogroup W-135 meningococcal disease during the Hajj, 2000. Emerg Infect Dis 2003;9:665-71. (Pubitemid 36676361)
24. von Gottberg A, du Plessis M, Cohen C, et al. Emergence of endemic serogroup W135 meningococcal disease associated with a high mortality rate in South Africa. Clin Infect Dis 2008;46:377-86. (Pubitemid 351263521)
25. Wilder-Smith A. Meningococcal vaccine in travelers. Curr Opin Infect Dis 2007;20:454-60. (Pubitemid 47359640)
26. Davidsen T, Tønjum T. Meningococcal genome dynamics. Nat Rev Microbiol 2006;4:11-22. (Pubitemid 43135283)
27. Mastrantonio P, Sofia T, Neri A, et al. Characterisation of invasive meningococcal isolates from Italian children and adolescents. Clin Microbiol Infect 2007;13:100-3. (Pubitemid 44869217)
28. Gasparini R, Rizzetto R, Sasso T, et al. Seroprevalence of bactericidal antibody against Neisseria meningitidis serogroup C in pre-vaccinal era: the Italian epidemiological scenario. Vaccine 2009;27:3435-8.
29. Germinario C, Tafuri S, Napoli C, et al. Young-adult carriers of Neisseria meningitidis in Puglia (Italy): will the pattern of circulating meningococci change following the introduction of meningococcal serogroup C conjugate vaccines? Hum Vaccin 2010;6:1025-7.
30. Bröker M, Fantoni S. Meningococcal disease: a review on available vaccines and vaccines in development. Minerva Med 2007;98:575-89. (Pubitemid 350240285)
31. Granoff DM. Review of meningococcal group B vaccines. Clin Infect Dis 2010;50(Suppl 2):S54-65.
32. de Moraes JC, Perkins BA, Camargo MC, et al. Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil. Lancet 1992;340:1074-8.
33. Panatto D, Amicizia D, Lai PL, et al. Neisseria meningitidis B vaccines. Expert Rev Vaccines 2011;10:1337-51.
34. Findlow J, Lowe A, Deane S, et al. Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vescicle vaccine in toddlers and school children. Vaccine 2005;23:2623-7. (Pubitemid 40380807)
35. Holst J. Strategies for development of universal vaccines against meningococcal serogroup B disease: the most promising options and the challenges evaluating them. Hum Vaccin 2007;3:290-4.
36. Alfonsi V, D'Ancona F, Giambi C, et al; Regional Coordinators for Infectious Diseases and Vaccinations. Current immunization policies for pneumococcal, meningococcal C, varicella and rotavirus vaccinations in Italy. Health Policy 2011;103:176-83.